# Charles River Laboratories International, Inc.: filings

CRL · NYSE · CIK 1100682 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/crl.md) · [Financials](/companies/crl/financials.md) · [Filings](/companies/crl/filings.md) · [Insiders](/companies/crl/insiders.md)

## Reports and events: 278 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1093, 8-K 172, SC 13G/A 55, 10-Q 53, 144 43, DEFA14A 38, 4/A 29, 3 28, 5 26, 10-K 18, DEF 14A 18, UPLOAD 15, SC 13G 13, SD 13, ARS 11, CORRESP 10, SC 13D/A 9, SCHEDULE 13G/A 8, PX14A6G 7, S-8 7, S-3ASR 6, 8-K/A 4, SC 13D 4, SCHEDULE 13G 3, 5/A 2, DEFM14A 1, PREM14A 1, PRER14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-24 | 08:12 ET | [8-K](/filings/0001100682-26-000142.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001100682-26-000142 |
| 2026-08-05 | 09:21 ET | [10-Q](/filings/0001100682-26-000118.md) | Quarterly report, period 2026-06-27 | 0001100682-26-000118 |
| 2026-08-05 | 07:15 ET | [8-K](/filings/0001100682-26-000115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-26-000115 |
| 2026-05-11 | 17:01 ET | [8-K](/filings/0000950103-26-007060.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-26-007060 |
| 2026-05-07 | 16:14 ET | [10-Q](/filings/0001100682-26-000038.md) | Quarterly report, period 2026-03-28 | 0001100682-26-000038 |
| 2026-05-07 | 07:14 ET | [8-K](/filings/0001100682-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-26-000036 |
| 2026-03-31 | 07:50 ET | [DEF 14A](/filings/0001104659-26-037367.md) | Proxy statement, period 2026-05-05 | 0001104659-26-037367 |
| 2026-02-25 | 07:34 ET | [8-K](/filings/0001628280-26-011395.md) | 7.01 Regulation FD disclosure | 0001628280-26-011395 |
| 2026-02-18 | 16:39 ET | [8-K](/filings/0000950103-26-002326.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950103-26-002326 |
| 2026-02-18 | 09:21 ET | [10-K](/filings/0001100682-26-000022.md) | Annual report, period 2025-12-27 | 0001100682-26-000022 |
| 2026-02-18 | 07:13 ET | [8-K](/filings/0001100682-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-26-000020 |
| 2026-01-13 | 08:10 ET | [8-K](/filings/0001628280-26-001905.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-26-001905 |
| 2026-01-09 | 16:18 ET | [8-K](/filings/0001628280-26-001603.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-001603 |
| 2025-12-03 | 07:28 ET | [8-K](/filings/0001628280-25-054902.md) | 7.01 Regulation FD disclosure | 0001628280-25-054902 |
| 2025-11-17 | 08:06 ET | [8-K](/filings/0001628280-25-052484.md) | 8.01 Other events | 0001628280-25-052484 |
| 2025-11-05 | 09:12 ET | [10-Q](/filings/0001100682-25-000043.md) | Quarterly report, period 2025-09-27 | 0001100682-25-000043 |
| 2025-11-05 | 07:16 ET | [8-K](/filings/0001100682-25-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000041 |
| 2025-09-19 | 16:14 ET | [8-K/A](/filings/0000950103-25-011896.md) | 5.02 Departure or appointment of officers or directors | 0000950103-25-011896 |
| 2025-09-16 | 07:10 ET | [8-K](/filings/0000950103-25-011676.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-25-011676 |
| 2025-08-06 | 09:07 ET | [10-Q](/filings/0001100682-25-000034.md) | Quarterly report, period 2025-06-28 | 0001100682-25-000034 |
| 2025-08-06 | 07:08 ET | [8-K](/filings/0001100682-25-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000032 |
| 2025-05-23 | 16:12 ET | [8-K](/filings/0001100682-25-000023.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001100682-25-000023 |
| 2025-05-07 | 09:09 ET | [10-Q](/filings/0001100682-25-000021.md) | Quarterly report, period 2025-03-29 | 0001100682-25-000021 |
| 2025-05-07 | 07:15 ET | [8-K](/filings/0000950103-25-005798.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-25-005798 |
| 2025-05-07 | 07:08 ET | [8-K](/filings/0001100682-25-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000019 |
| 2025-04-02 | 08:00 ET | [DEF 14A](/filings/0001104659-25-030908.md) | Proxy statement, period 2025-05-20 | 0001104659-25-030908 |
| 2025-02-21 | 16:30 ET | [8-K](/filings/0001100682-25-000014.md) | 8.01 Other events | 0001100682-25-000014 |
| 2025-02-19 | 09:07 ET | [10-K](/filings/0001100682-25-000011.md) | Annual report, period 2024-12-28 | 0001100682-25-000011 |
| 2025-02-19 | 07:19 ET | [8-K](/filings/0001100682-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000009 |
| 2025-01-14 | 08:04 ET | [8-K](/filings/0001100682-25-000003.md) | 7.01 Regulation FD disclosure | 0001100682-25-000003 |
| 2024-12-13 | 16:42 ET | [8-K](/filings/0000950103-24-017767.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-24-017767 |
| 2024-11-06 | 09:16 ET | [10-Q](/filings/0001100682-24-000035.md) | Quarterly report, period 2024-09-28 | 0001100682-24-000035 |
| 2024-11-06 | 07:21 ET | [8-K](/filings/0001100682-24-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-24-000033 |
| 2024-08-07 | 09:15 ET | [10-Q](/filings/0001100682-24-000027.md) | Quarterly report, period 2024-06-29 | 0001100682-24-000027 |
| 2024-08-07 | 07:21 ET | [8-K](/filings/0001100682-24-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-24-000025 |
| 2024-05-10 | 16:07 ET | [8-K](/filings/0001100682-24-000020.md) | 5.07 Shareholder vote results | 0001100682-24-000020 |
| 2024-05-09 | 09:17 ET | [10-Q](/filings/0001100682-24-000018.md) | Quarterly report, period 2024-03-30 | 0001100682-24-000018 |
| 2024-05-09 | 07:31 ET | [8-K](/filings/0001100682-24-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-24-000014 |
| 2024-03-29 | 08:00 ET | [DEF 14A](/filings/0001104659-24-040854.md) | Proxy statement, period 2024-05-08 | 0001104659-24-040854 |
| 2024-02-14 | 09:19 ET | [10-K](/filings/0001100682-24-000007.md) | Annual report, period 2023-12-30 | 0001100682-24-000007 |
| 2024-02-14 | 07:30 ET | [8-K](/filings/0001157523-24-000238.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-24-000238 |
| 2024-01-24 | 16:34 ET | [8-K](/filings/0001100682-24-000004.md) | 5.02 Departure or appointment of officers or directors | 0001100682-24-000004 |
| 2024-01-16 | 16:32 ET | [8-K](/filings/0001100682-24-000002.md) | 5.02 Departure or appointment of officers or directors | 0001100682-24-000002 |
| 2023-11-15 | 08:31 ET | [8-K](/filings/0001100682-23-000025.md) | 8.01 Other events | 0001100682-23-000025 |
| 2023-11-08 | 09:06 ET | [10-Q](/filings/0001100682-23-000022.md) | Quarterly report, period 2023-09-30 | 0001100682-23-000022 |
| 2023-11-08 | 07:30 ET | [8-K](/filings/0001157523-23-001678.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001678 |
| 2023-08-09 | 09:09 ET | [10-Q](/filings/0001100682-23-000018.md) | Quarterly report, period 2023-07-01 | 0001100682-23-000018 |
| 2023-08-09 | 07:30 ET | [8-K](/filings/0001157523-23-001294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001294 |
| 2023-05-15 | 16:02 ET | [8-K](/filings/0001100682-23-000012.md) | 5.07 Shareholder vote results | 0001100682-23-000012 |
| 2023-05-11 | 09:08 ET | [10-Q](/filings/0001100682-23-000009.md) | Quarterly report, period 2023-04-01 | 0001100682-23-000009 |

Page 1 of 6. [Older](/companies/crl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:52 ET. No prices; not investment advice.